10-Q: Q3 2024 Earnings Report
8-K: X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update
10-Q: Q2 2024 Earnings Report
8-K: X4 Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
10-Q: Q1 2024 Earnings Report
8-K: X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
X4 Pharmaceuticals, Inc.'s (NASDAQ:XFOR) Market Cap Decline of US$42m May Not Have as Much of an Impact on Institutional Owners After a Year of 7.0% Returns
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)